1/24/2020 6:31:34 AM
Anat Hakim To Join Lilly On February 3, 2020 As SVP And General Counsel
1/14/2020 6:50:31 AM
Lilly Unveils Lower-priced Versions Of Humalog® Mix75/25™ KwikPen® And Humalog® Junior KwikPen®
1/13/2020 6:32:48 AM
Lilly Says Phase 3 ORIENT-11 Study Met Predefined Primary Endpoint As First-Line Therapy In Nonsquamous NSCLC
1/12/2020 11:33:23 PM
Innovent Biologics: Phase 3 ORIENT-11 Study Met Predefined Primary Endpoint As First-Line Therapy In Nonsquamous NSCLC
1/10/2020 6:32:20 AM
Lilly To Acquire Dermira For $18.75/shr Or About $1.1 Bln In All-cash Transaction
1/9/2020 8:02:35 AM
Eli Lilly And Strateos Unveil New Robotic Laboratory In San Diego, California
12/30/2019 1:23:22 PM
U.S. District Court Rules In Favor Of Lilly In Alimta Vitamin Regimen Patent Lawsuit
12/30/2019 6:47:12 AM
Lilly Opens LIBRETTO-531 Clinical Trial For Selpercatinib For Treatment-naïve RET-mutant MTC Patients
12/19/2019 6:47:31 AM
Lilly Announces Campaign To Increase Awareness Of Insulin Cost-Saving Options
12/18/2019 6:49:09 AM
Lilly Launches Long-Term, Real-World Evidence Study Of Emgality, TRIUMPH
12/17/2019 6:31:40 AM
Lilly Sees 2020 Revenue To Be Between $23.6 Bln And $24.1 Bln
12/16/2019 4:36:00 PM
Lilly Declares Q1 Dividend Of $0.74/share, Payable March 10/ Record Feb. 14
12/16/2019 4:27:30 PM
Eli Lilly And Co. (LLY) Declares $ 0.74 Dividend for Q1 20, Record Date 2/14/2020